Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: A systematic review and network meta-analysis of 14,533 patients over 29 randomized clinical trials-Reference-Cited by-同舟云学术

Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: A systematic review and network meta-analysis of 14,533 patients over 29 randomized clinical trials

Published:2019-11 Issue: Volume:143 Page:102-116
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Sekine Leo,Ziegelmann Patrícia Klarmann,Manica Denise,Pithan Carolina da Fonte,Sosnoski Monalisa,Morais Vinicius Daudt,Falcetta Frederico Soares,Ribeiro Mariana Rangel,Salazar Ana Paula,Ribeiro Rodrigo Antonini

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference88 articles.

1. Assessing the benefit of continuous treatment in the first trial (MM-020): impact of response in patients with transplant-ineligible newly diagnosed multiple myeloma;Bahlis;Haematologica,2015

2. Impact of response in patients (pts) with stem cell transplant (SCT)-ineligible newly diagnosed multiple myeloma (NDMM) treated with continuous lenalidomide + low-dose dexamethasone (Rd) in the first trial;Bahlis;Clin. Lymphoma Myeloma Leuk.,2015

3. Review of the reporting of survival analyses within randomised controlled trials and the implications for meta-analysis;Batson;PLoS One,2016

4. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma;Benboubker;N. Engl. J. Med.,2014

5. Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis;Blommestein;Haematologica,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews;Value in Health Regional Issues;2024-09

2. Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant;Cochrane Database of Systematic Reviews;2024-05-02

3. Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant;Hematological Oncology;2022-07-11

4. Establishment of a prediction model for disease progression within one year in newly diagnosed multiple myeloma patients;Hematology;2022-05-26

5. Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis;Advances in Therapy;2022-03-05